Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022
mBio · 2023
DOI: 10.1128/mbio.00499-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2023. Verfasst von C M C Rodrigues und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Meningococcal Vaccines, Meningococcal Infections, Neisseria meningitidis, Neisseria meningitidis, Serogroup B. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Thrasher Research Fund.
Abstract (Originalsprache)
This study demonstrates the value of postimplementation genomic surveillance of vaccine-preventable pathogens in providing information on real-world vaccine performance. The data are consistent with 2 and 3 doses of Bexsero, delivered according to schedule, providing good protection against invasive disease caused by meningococci deduced from genomic data to be vaccine preventable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, University of Oxford, Oxford, United Kingdom.
- Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Department of Paediatrics, Imperial College Healthcare NHS Trust, London, United Kingdom.
- Public Health Scotland, Glasgow/Edinburgh, United Kingdom.
- Bacterial Respiratory Infection Service, Scottish Microbiology Reference Laboratory, Glasgow Royal Infirmary, Glasgow, United Kingdom.
- College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital & School, University of Glasgow, Glasgow, United Kingdom.
ORCID-Profile: C M C Rodrigues, M C J Maiden
Förderung
- Wellcome Trust
- Thrasher Research Fund
Zitieren
APA
Rodrigues, C. M. C., MacDonald, L., Ure, R., Smith, A., Cameron, J. C., & Maiden, M. C. J. (2023). Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022. mBio. https://doi.org/10.1128/mbio.00499-23
Vancouver
Rodrigues CMC, MacDonald L, Ure R, Smith A, Cameron JC, Maiden MCJ. Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022. mBio. 2023. doi:10.1128/mbio.00499-23
BibTeX
@article{Rodrigues2023,
author = {Rodrigues, C M C and MacDonald, L and Ure, R and Smith, A and Cameron, J C and Maiden, M C J},
title = {Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022},
journal = {mBio},
year = {2023},
doi = {10.1128/mbio.00499-23}
}
EUVIMED